The Journal of Immunology, Vol 148, Issue 11 3610-3617, Copyright © 1992 by American Association of Immunologists

ARTICLES

Identification of sites for distinct DNA binding proteins including Oct- 1 and Oct-2 in the Cr2 gene

SM Christensen, BK Martin, SS Tan and JH Weis
Department of Pathology, University of Utah School of Medicine, Salt Lake City 84132.

The murine Cr2 gene produces two distinct products in a variety of murine cell types. Both of these transcripts appear to initiate from the same position within the gene but vary from one another via an alternative splicing event within the coding exons. An analysis of those gene sequences that might control the cell specific expression of the Cr2 gene has identified a region of Cr2 5' of the transcription start site that is conserved in both the murine Cr2 and human CR2 genes. When this region was examined using the gel shift assay with nuclear extracts from cells expressing Cr2 (B cells) and those that do not (T cells and fibroblasts), at least four distinct proteins were identified that bound to at least three distinct sites. The DNA sequence recognized by two of these proteins is the octamer sequence recognized by a family of transcriptional regulators including the B cell specific Oct-2 protein. During an acute bacterial infection, the levels of Oct-2 and Cr2 mRNA are both depressed. This suggests that the Oct-2 protein directly controls the transcriptional activity of the Cr2 gene and that during such an infection, the levels of Ag receptors on B cells (Ig and complement receptors) are diminished.

This article has been cited by other articles:

				G. Qiu and J. S. Hill Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages J. Lipid Res., October 1, 2007; 48(10): 2112 - 2122. [Abstract] [Full Text] [PDF]

				I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]

				C. Brunner and T. Wirth Btk expression is controlled by Oct and BOB.1/OBF.1. Nucleic Acids Res., January 1, 2006; 34(6): 1807 - 1815. [Abstract] [Full Text] [PDF]

				V. E. H. Wang, D. Tantin, J. Chen, and P. A. Sharp B cell development and immunoglobulin transcription in Oct-1-deficient mice PNAS, February 17, 2004; 101(7): 2005 - 2010. [Abstract] [Full Text] [PDF]

				V. E. H. Wang, T. Schmidt, J. Chen, P. A. Sharp, and D. Tantin Embryonic Lethality, Decreased Erythropoiesis, and Defective Octamer-Dependent Promoter Activation in Oct-1-Deficient Mice Mol. Cell. Biol., February 1, 2004; 24(3): 1022 - 1032. [Abstract] [Full Text] [PDF]

				M. D. Zabel, B. L. Byrne, J. J. Weis, and J. H. Weis Cell-Specific Expression of the Murine CD21 Gene Depends on Accessibility of Promoter and Intronic Elements J. Immunol., October 15, 2000; 165(8): 4437 - 4445. [Abstract] [Full Text] [PDF]

				M. D. Zabel, J. J. Weis, and J. H. Weis Lymphoid Transcription of the Murine CD21 Gene Is Positively Regulated by Histone Acetylation J. Immunol., September 1, 1999; 163(5): 2697 - 2703. [Abstract] [Full Text] [PDF]

				K L Cepek, D I Chasman, and P A Sharp Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes & Dev., August 15, 1996; 10(16): 2079 - 2088. [Abstract] [PDF]

				S S Tan and J H Weis Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. Genome Res., November 1, 1992; 2(2): 137 - 143. [Abstract] [PDF]